These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Appraisal of mechanisms of radioprotection and therapeutic approaches of radiation countermeasures. Mishra KN; Moftah BA; Alsbeih GA Biomed Pharmacother; 2018 Oct; 106():610-617. PubMed ID: 29990850 [TBL] [Abstract][Full Text] [Related]
7. Radioprotective countermeasures for radiation injury (Review). Liu L; Liang Z; Ma S; Li L; Liu X Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36799170 [TBL] [Abstract][Full Text] [Related]
8. [Radiomitigators: prospects for use in medical radiation protection]. Grebeniuk AN; Legeza VI; Tarumov RA Voen Med Zh; 2014 Jun; 335(6):39-43. PubMed ID: 25286573 [TBL] [Abstract][Full Text] [Related]
10. Radiation Protection and Mitigation by Natural Antioxidants and Flavonoids: Implications to Radiotherapy and Radiation Disasters. Yahyapour R; Shabeeb D; Cheki M; Musa AE; Farhood B; Rezaeyan A; Amini P; Fallah H; Najafi M Curr Mol Pharmacol; 2018; 11(4):285-304. PubMed ID: 29921213 [TBL] [Abstract][Full Text] [Related]
11. Acute radiation effect in the brain in infant rats: Neurocognitive and histopathological examination. Gorker I; Yurut-Caloglu V; Karadag H; Caloglu M; Altaner S; Cengiz H; Ozen A J BUON; 2011; 16(2):297-303. PubMed ID: 21766501 [TBL] [Abstract][Full Text] [Related]
12. [Current status and perspectives of using radioprotectors in clinical practice]. Bondaruk OS; Moskalets' OI Lik Sprava; 2003; (7):3-12. PubMed ID: 14723126 [TBL] [Abstract][Full Text] [Related]
13. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with 'standard of care' medicinal and procedures not requiring regulatory approval for use. Singh VK; Hanlon BK; Santiago PT; Seed TM Int J Radiat Biol; 2017 Sep; 93(9):885-906. PubMed ID: 28657400 [TBL] [Abstract][Full Text] [Related]
14. The role of amifostine as a radioprotector. Wasserman TH; Brizel DM Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962 [TBL] [Abstract][Full Text] [Related]
15. [The classification of radiation protective agents as the reflection of the present state and development perspective, of current radiation pharmacology]. Vasin VM Radiats Biol Radioecol; 2013; 53(5):459-67. PubMed ID: 25434165 [TBL] [Abstract][Full Text] [Related]
16. [Medical protection during radiation accidents: some results and lessons of the Chernobyl accident]. Legeza VI; Grebeniuk AN; Zatsepin VV Radiats Biol Radioecol; 2011; 51(1):70-5. PubMed ID: 21520618 [TBL] [Abstract][Full Text] [Related]
17. The potential of amifostine: from cytoprotectant to therapeutic agent. Santini V; Giles FJ Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165 [TBL] [Abstract][Full Text] [Related]
18. [Current problems of chemical radiation protection of organisms]. Kudriashov IuB; Goncharenko EN Radiats Biol Radioecol; 1999; 39(2-3):197-211. PubMed ID: 10366942 [TBL] [Abstract][Full Text] [Related]
19. [Chemical protection of golden hamsters against ionizing radiation]. Saĭkova VA; Sverdlov AG Radiobiologiia; 1983; 23(2):182-6. PubMed ID: 6302728 [TBL] [Abstract][Full Text] [Related]
20. Bacq and Alexander Award lecture--chemical radioprotection: past, present, and future prospects. Maisin JR Int J Radiat Biol; 1998 Apr; 73(4):443-50. PubMed ID: 9587083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]